| Ytd | 9.42% | |
| 1y | 33.41% |
| Open | 877.33 | Prev Close | 879.87 | Low | 877.33 | High | 899.12 | Mkt Cap | 104.88B |
| Vol | 33.83K | Avg Vol | 1.14M | EPS | 40.82 | P/E | 21.94 | Forward P/E | 17.21 |
| Beta | 0.30 | Short Ratio | 3.29 | Inst. Own | 94.92% | Dividend | 3.28 | Div Yield | 0.38 |
| Ex Div Date | 09-01 | Earning | 08-05 | 50-d Avg | 802.07 | 200-d Avg | 838.10 | 1yr Est | 983.33 |
Wells Fargo analyst Stephen Baxter maintains McKesson (NYSE:MCK) with a Equal-Weight and raises t
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
McKesson NYSE: MCK reported fiscal first-quarter 2027 results that exceeded its expectations, citing
McKesson delivered strong Q1 results, with EPS up 20% and revenues rising 7.7% while modestly raisin
McKesson (NYSE:MCK) has outperformed the market over the past 5 years by 23.04% on an annualized bas
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and raises the price targ
UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target f
McKesson shares rise after fiscal Q1 earnings and revenues beat estimates, powered by specialty grow
Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and
McKesson raises fiscal 2027 earnings guidance after pharma profit rises 19%, while specialty demand,
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t
These healthcare giants can deliver steady gains.
Revenue: $105.4 billion, an increase of 8% year over year.Adjusted Earnings Per Share: $9.93, an inc
McKesson Corporation (MCK) Q1 2027 Earnings Call Transcript
McKesson (MCK) came out with quarterly earnings of $9.93 per share, beating the Zacks Consensus Esti
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter e
Drug distributor McKesson on Wednesday raised its annual profit forecast after beating first-quarter
McKesson (NYSE:MCK) raises FY2027 Adj EPS guidance from $43.80-$44.60 to $44.20-$45.00 vs $44.26 ana
McKesson (NYSE:MCK) reported quarterly earnings of $9.93 per share which beat the analyst consensus
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2027 first
A few sectors have dominated the market this year, and healthcare isn't one of them. Many stocks in
McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs,
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and raises the price
The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of $
TD Cowen analyst Charles Rhyee maintains McKesson (NYSE:MCK) with a Buy and lowers the price targ
July 8, 2026 records indicate that Representative Ritchie Torres filed a purchase of McKesson (NYSE:
Barclays analyst Glen Santangelo maintains McKesson (NYSE:MCK) with a Overweight and lowers the p
The battle between Amazon.com and Walmart has produced a new leader for the Fortune 500 list for 202
Apollo Funds invested $1.25 billion in convertible preferred equity of MMS to acquire an approximate
https://www.bloomberg.com/news/articles/2026-05-18/merck-starts-seven-part-high-grade-bond-sale-to-f
Citigroup analyst Daniel Grosslight maintains McKesson (NYSE:MCK) with a Buy and lowers the price
Wells Fargo analyst Stephen Baxter maintains McKesson (NYSE:MCK) with a Equal-Weight and lowers t
UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and raises the price target f
JP Morgan analyst Lisa Gill maintains McKesson (NYSE:MCK) with a Overweight and lowers the price
Nasdaq jumps 1.6% to record highs Friday as semiconductor rally and stronger-than-expected April pay
Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and
UBS analyst Kevin Caliendo maintains McKesson (NYSE:MCK) with a Buy and lowers the price target f
McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has ente
Evercore ISI Group analyst Elizabeth Anderson maintains McKesson (NYSE:MCK) with a Outperform and
B of A Securities analyst Michael Cherny maintains McKesson (NYSE:MCK) with a Buy and lowers the
Gavin Newsom praised Apple's 50 years of innovation as numerous major corporations and tech bill